NBIX icon

Neurocrine Biosciences

198 hedge funds and large institutions have $3.98B invested in Neurocrine Biosciences in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 52 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
198
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$61.7M
Puts
$18.9M
Net Calls
Net Calls Change

Top Buyers

1 +$67.8M
2 +$20.1M
3 +$19M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$16.6M
5
Norges Bank
Norges Bank
Norway
+$14.1M

Top Sellers

1 -$53.2M
2 -$48.4M
3 -$39.6M
4
O
OrbiMed
New York
-$35.3M
5
PA
Perceptive Advisors
New York
-$21.8M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$11.2M
52
$11M
53
$10.9M
54
$10.9M
55
$10.5M
56
$9.84M
57
$9.2M
58
$8.7M
59
$8.29M
60
$7.83M
61
$7.45M
62
$7.37M
63
$7.27M
64
$7.23M
65
$7.19M
66
$7.16M
67
$7M
68
$6.93M
69
$6.92M
70
$6.89M
71
$6.88M
72
$6.44M
73
$6.04M
74
$5.85M
75
$5.38M